Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Title:Meet Our Regional Editor
Volume: 17 Issue: 1
Author(s): K. Tsuchida
Affiliation:
Export Options
About this article
Cite this article as:
Tsuchida K. , Meet Our Regional Editor, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2018; 17 (1) . https://dx.doi.org/10.2174/187152301701180827120253
DOI https://dx.doi.org/10.2174/187152301701180827120253 |
Print ISSN 1871-5230 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-614X |
27
2
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
In Vivo Gastroprotective Effect of Nanoparticles: Influence of Chemical Composition and Volume Fraction
Current Pharmaceutical Design SV40 Pseudovirions as Highly Efficient Vectors for Gene Transfer and their Potential Application in Cancer Therapy
Current Pharmaceutical Biotechnology VIP in Neurological Diseases: More Than A Neuropeptide
Endocrine, Metabolic & Immune Disorders - Drug Targets Connecting A Tumor to the Environment
Current Pharmaceutical Design Sphingolipid Modulation: A Strategy for Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Personalizing HIV Therapeutics in Resource-Limited Rural Communities: Lessons Learned From the Use of New Tools in Africa
Current Pharmacogenomics and Personalized Medicine Protective Role of Natural Products in Glioblastoma Multiforme: A Focus on Nitric Oxide Pathway
Current Medicinal Chemistry Current and Emerging Therapies in Primary Myelofibrosis
Cardiovascular & Hematological Disorders-Drug Targets Editorial [Hot Topic: Oxidative Stress and Cellular Homeostasis (Executive Editor: Victor M. Victor)]
Current Pharmaceutical Design The Mammalian Tachykinin Ligand-Receptor System: An Emerging Target for Central Neurological Disorders
CNS & Neurological Disorders - Drug Targets A Role for Leptin in the Systemic Inflammatory Response Syndrome (SIRS) and in Immune Response, an Update
Current Medicinal Chemistry Editorial [ Adhesion Molecules and Drug Targeting Executive Editor: Seetharama D.S. Jois ]
Current Pharmaceutical Design Patent Selections
Recent Patents on Inflammation & Allergy Drug Discovery Influence of H2O2 Formed In Situ on the Photodegradation of Ibuprofen and Ketoprofen
Current Physical Chemistry Passive and Active Tumour Targeting with Nanocarriers
Current Drug Discovery Technologies Mining the Dark Matter of the Cancer Proteome for Novel Biomarkers
Current Cancer Therapy Reviews Pharmacology and Clinical Effect of Platonin, a Cyanine Photosensitizing Dye: Potential Molecular Targets
Current Pharmaceutical Biotechnology Anti-Inflammatory Activity and Cheminformatics Analysis of New Potent 2-Substituted 1-Methyl-5-Nitroindazolinones
Current Topics in Medicinal Chemistry The Urokinase Receptor in the Central Nervous System
CNS & Neurological Disorders - Drug Targets Relationship Between the Chemokine Receptor CCR5 and Microglia in Neurological Disorders: Consequences of Targeting CCR5 on Neuroinflammation, Neuronal Death and Regeneration in a Model of Epilepsy
CNS & Neurological Disorders - Drug Targets